NIH-funded research R01 grant

Understanding how bone cells respond to bacterial infections

Official title: Mechanisms of osteocyte induction and regulation of pathogen-induced osteolysis

Funded at Indiana University Indianapolis · NIH-10890641 · Data updated 2026-11-12

This study is looking at how a special type of bone cell called osteocytes helps the body react to bacterial infections that can cause bone loss, like osteomyelitis and periodontitis, and it aims to find new ways to prevent this bone loss.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIndiana University Indianapolis
NIH-funded
Lab location1 site (Indianapolis, United States)
Project startJuly 18, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$415,971
NIH project number5R01DE032036-02
Project IDNIH-10890641 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from osteomyelitis or periodontitis, particularly those experiencing significant bone loss.

Less likely to help

Patients with bone loss not related to bacterial infections or those with other underlying conditions affecting bone health may not benefit from this research.

What this research studies

This research investigates the role of osteocytes, a type of bone cell, in the body's response to bacterial infections that can lead to bone loss, such as osteomyelitis and periodontitis. By studying mice with specific genetic modifications, researchers aim to uncover the molecular mechanisms that trigger inflammation and bone resorption in response to bacterial signals. The approach includes analyzing the secretion of inflammatory factors from osteocytes and their impact on immune cell behavior. This could lead to new therapeutic strategies targeting these pathways to prevent bone loss.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments that prevent or reduce bone loss associated with bacterial infections.

How similar studies have gone: Previous research has shown that targeting specific pathways in bone cells can lead to significant improvements in bone health, suggesting a promising avenue for this investigation.

Where this research is happening

  • Indiana University Indianapolis
    Indianapolis, United States
    Active

Researchers

  • Principal investigator: Ueki, Yasuyoshi — Indiana University Indianapolis
  • Study coordinator: Ueki, Yasuyoshi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.